Medusa Pharmaceuticals: Treating the Untreatable
Medusa Pharmaceuticals, founded in 2021 by Dr. James Duboff and Professor Peter Sarkies, has developed a groundbreaking approach to combat antibiotic resistance by combining alkylating agents with aminoglycoside antibiotics to restore their efficacy. Focused on conditions like cystic fibrosis, their method could reduce drug toxicity and address antimicrobial resistance, with promising early results and plans for further development...
Megan Thomas
January 17, 2025